Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
- 2024
August 2024 - 114 products
L
IP
CI
Ticagrelor NOBEL 60 mg
56
20.48
38.70
10 %
Coated tablets: Ticagrelorum 60 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Ticagrelor NOBEL 60 mg
3 x 56
61.43
83.20
10 %
Coated tablets: Ticagrelorum 60 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Ticagrelor NOBEL 90 mg
56
23.70
42.20
10 %
Coated tablets: Ticagrelorum 90 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Ticagrelor NOBEL 90 mg
98
41.47
61.55
10 %
Coated tablets: Ticagrelorum 90 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Ticagrelor NOBEL 90 mg
3 x 56
71.10
93.75
10 %
Coated tablets: Ticagrelorum 90 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
CM
Lorazepam axapharm 1 mg
20
2.23
11.65
10 %
Tablets: Lorazepamum 1 mg
axapharm ag
B / SL / SG
FB
G
L
IP
CI
CM
Lorazepam axapharm 1 mg
50
3.81
13.40
10 %
Tablets: Lorazepamum 1 mg
axapharm ag
B / SL / SG
FB
G
L
IP
CM
Lorazepam axapharm 2.5 mg
20
2.75
12.20
10 %
Tablets: Lorazepamum 2.5 mg
axapharm ag
B / SL / SG
FB
G
L
IP
CM
Lorazepam axapharm 2.5 mg
50
6.29
16.05
10 %
Tablets: Lorazepamum 2.5 mg
axapharm ag
B / SL / SG
FB
G
L
IP
Paclitaxel-Albumin Spirig HC 5
mg/ml
178.18
210.20
10 %
Pulver zur Herstellung einer Infusionsdispersion: Paclitaxelum 100 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
CI
Dimethylfumarat Sandoz 120 mg
14
88.87
113.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Dimethylfumarat Sandoz 240 mg
56
355.51
403.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Dimethylfumarat Sandoz 240 mg
168
1066.55
1176.35
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Dimethylfumarat Viatris 120 mg
14
88.87
113.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
Dimethylfumarat Viatris 240 mg
56
355.51
403.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
Dimethylfumarat Viatris 240 mg
168
1066.55
1176.35
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Dimethylfumarat-Mepha
Teva 120 mg
14
88.87
113.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Dimethylfumarat-Mepha
Teva 240 mg
56
355.51
403.05
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Dimethylfumarat-Mepha
Teva 240 mg
168
1066.55
1176.35
10 %
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
V/S
Comirnaty JN.1 0.042 mg
10
702.46
770.85
10 %
Pfizer AG
B / SL
FB
G
L
IP
CI
Ebglyss 250 mg/2 ml
2
1916.93
2101.20
10 %
Injection solution in prefilled syringe: Lebrikizumabum 250mg / 2ml
Almirall AG
B / SL
FB
G
L
IP
Ruxience 100 mg/10 ml
203.40
237.65
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
Pfizer AG
A / SL
FB
G
L
IP
Ruxience 500 mg/50 ml
1051.32
1159.80
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
Pfizer AG
A / SL
FB
G
L
IP
CI
Fruzaqla 1 mg
21
847.86
938.50
10 %
Capsules: Fruquintinibum 1 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
Fruzaqla 5 mg
21
3782.91
4130.55
10 %
Capsules: Fruquintinibum 5 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Ebglyss 250 mg/2 ml
2 x 2 ml
1916.93
2101.20
10 %
Injektionslösung in Fertigpen: Lebrikizumabum 250mg / 2ml
Almirall AG
B / SL
FB
G
L
IP
TECENTRIQ subkutan 1875
mg/15ml
4370.35
4769.45
10 %
Injektionslösung zur subkutanen Anwendung: Atezolizumabum 1875mg / 15ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
V/S
Abrysvo
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
V/S
Abrysvo
5
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
V/S
Abrysvo
10
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty JN.1 30 μg
10
PR
PR
k.A.
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty JN.1 10 μg
10
PR
PR
k.A.
Pfizer AG
B
FB
G
Sugammadex OrPha 200 mg/2 ml
10
PR
PR
k.A.
OrPha Swiss GmbH
B
FB
G
Latano-Vision SDU 50
μg/ml
30 x 0.2 ml
PR
PR
k.A.
Eye drops: Latanoprostum 50 µg/ml
OmniVision AG
B
FB
G
Latano-Vision SDU 50
μg/ml
90 x 0.2 ml
PR
PR
k.A.
Eye drops: Latanoprostum 50 µg/ml
OmniVision AG
B
FB
G
IP
Tranexam Labatec 500 mg/5 mL
5
PR
PR
k.A.
Injection solution: Acidum Tranexamicum 500mg / 5ml
Labatec Pharma SA
B
FB
G
IP
Tranexam Labatec 1000
mg/10 mL
5
PR
PR
k.A.
Injection solution: Acidum Tranexamicum 1000mg / 10ml
Labatec Pharma SA
B
FB
G
IP
CI
Ebglyss 250 mg/2 ml
PR
PR
k.A.
Injection solution in prefilled syringe: Lebrikizumabum 250mg / 2ml
Almirall AG
B
FB
G
IP
CI
Mebucaïne Dolo Honig-
Zitrone 8.75 mg
16
PR
PR
k.A.
Lozenges: Flurbiprofenum 8.75 mg
Spirig HealthCare AG
D
FB
G
CM
Efferalgan Kinder
90 ml
PR
PR
k.A.
Sirup: Paracetamolum 30 mg/ml
UPSA Switzerland AG
D
FB
G
CM
Efferalgan Kinder
90 ml
PR
PR
k.A.
Sirup: Paracetamolum 30 mg/ml
UPSA Switzerland AG
D
FB
G
CM
Efferalgan Kinder
150 ml
PR
PR
k.A.
Sirup: Paracetamolum 30 mg/ml
UPSA Switzerland AG
D
FB
G
CM
Efferalgan Kinder
150 ml
PR
PR
k.A.
Sirup: Paracetamolum 30 mg/ml
UPSA Switzerland AG
D
FB
G
Viant
5
PR
PR
k.A.
Lyophilisate: 13 Active Agents
B. Braun Medical SA
B
FB
G
Viant
10
PR
PR
k.A.
Lyophilisate: 13 Active Agents
B. Braun Medical SA
B
FB
G
IP
CI
Dimetindene Leman 1 mg/g
30 g
PR
PR
k.A.
Gel: Dimetindeni Maleas 1 mg
Leman SKL SA
D
FB
G
IP
CI
Dimetindene Leman 1 mg/g
50 g
PR
PR
k.A.
Gel: Dimetindeni Maleas 1 mg
Leman SKL SA
D
FB
G
IP
CI
Atorvastatin-Mepha 10 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 10 mg
Mepha Pharma AG
B
FB
G
IP
CI
Atorvastatin-Mepha 10 mg
90
PR
PR
k.A.
Coated tablets: Atorvastatinum 10 mg
Mepha Pharma AG
B
FB
G
IP
CI
Atorvastatin-Mepha 10 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 10 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 20 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 20 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 20 mg
90
PR
PR
k.A.
Coated tablets: Atorvastatinum 20 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 20 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 20 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 40 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 40 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 40 mg
90
PR
PR
k.A.
Coated tablets: Atorvastatinum 40 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 40 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 40 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 80 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 80 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 80 mg
90
PR
PR
k.A.
Coated tablets: Atorvastatinum 80 mg
Mepha Pharma AG
B
FB
G
IP
Atorvastatin-Mepha 80 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 80 mg
Mepha Pharma AG
B
FB
G
Eltrombopag NOBEL 12.5 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 12.5 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 25 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 25 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 50 mg
14
PR
PR
k.A.
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 50 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 75 mg
28
PR
PR
k.A.
Coated tablets: Eltrombopagum 75 mg
NOBEL Pharma Schweiz AG
A
FB
G
Levetiracetam-Neuraxpharm 250 mg
30
PR
PR
k.A.
Coated tablets: Levetiracetamum 250 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm 500 mg
20
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm 500 mg
100
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm 500 mg
200
PR
PR
k.A.
Coated tablets: Levetiracetamum 500 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm
1000 mg
30
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm
1000 mg
100
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Neuraxpharm
Switzerland AG
B
FB
G
Levetiracetam-Neuraxpharm
1000 mg
200
PR
PR
k.A.
Coated tablets: Levetiracetamum 1000 mg
Neuraxpharm
Switzerland AG
B
FB
G
IP
CI
Fabhalta 200 mg
56
PR
PR
k.A.
Capsules: Iptacopanum 200 mg
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
CM
Hanarbe 20 mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 20 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CI
CM
Hanarbe 20 mg
28
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 20 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CI
CM
Hanarbe 20 mg
98
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 20 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 40 mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 40 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 40 mg
28
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 40 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 40 mg
98
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 40 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 80 mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 80 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 80 mg
28
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 80 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CM
Hanarbe 80 mg
98
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 80 mg
Hasten
Biopharmaceutic
(Switzerland) AG
B
FB
G
IP
CI
Lorazepam Spirig HC 1 mg
20
PR
PR
k.A.
Tablets: Lorazepamum 1 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Lorazepam Spirig HC 1 mg
50
PR
PR
k.A.
Tablets: Lorazepamum 1 mg
Spirig HealthCare AG
B
FB
G
IP
Lorazepam Spirig HC 2.5 mg
20
PR
PR
k.A.
Tablets: Lorazepamum 2.5 mg
Spirig HealthCare AG
B
FB
G
IP
Lorazepam Spirig HC 2.5 mg
50
PR
PR
k.A.
Tablets: Lorazepamum 2.5 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Ebglyss 250 mg/2 ml
2 ml
PR
PR
k.A.
Injektionslösung in Fertigpen: Lebrikizumabum 250mg / 2ml
Almirall AG
B
FB
G
IP
CI
Nuvaring
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Nuvaring
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Nuvaring
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Nuvaring
3
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Nuvaring
3
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Nuvaring
3
PR
PR
k.A.
Vaginalring mit Applikator Btl: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
B
FB
G
IP
CI
Entresto 6 mg/6 mg
60
PR
PR
k.A.
filmüberzogenes Granulat: 2 Active Agents
Novartis Pharma
Schweiz AG
B
FB
G
IP
Entresto 15 mg/16 mg
60
PR
PR
k.A.
filmüberzogenes Granulat: 2 Active Agents
Novartis Pharma
Schweiz AG
B
FB
G
IP
Xalkori 20 mg
60
PR
PR
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 20 mg
Pfizer AG
A
FB
G
IP
Xalkori 50 mg
60
PR
PR
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 50 mg
Pfizer AG
A
FB
G
IP
Xalkori 150 mg
60
PR
PR
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 150 mg
Pfizer AG
A
FB
G
Dimethylfumarat Accord 120 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Accord Healthcare AG
B
FB
G
Dimethylfumarat Accord 240 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Accord Healthcare AG
B
FB
G
Dimethylfumarat Accord 240 mg
168
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Accord Healthcare AG
B
FB
G
Dimethylfumarat Sandoz eco 120 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Dimethylfumarat Sandoz eco 240 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Dimethylfumarat Sandoz eco 240 mg
168
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Dimethylfumarat Spirig HC 120 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Spirig HealthCare AG
B
FB
G
Dimethylfumarat Spirig HC 240 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Spirig HealthCare AG
B
FB
G
Dimethylfumarat Spirig HC 240 mg
168
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Spirig HealthCare AG
B
FB
G
Dimethylfumarat-Mepha 120 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 120 mg
Mepha Pharma AG
B
FB
G
Dimethylfumarat-Mepha 240 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Mepha Pharma AG
B
FB
G
Dimethylfumarat-Mepha 240 mg
168
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Mepha Pharma AG
B
FB
G
Dimethylfumarat-Mepha 240 mg
168
PR
PR
k.A.
magensaftresistente Hartkapseln: Dimethylis Fumaras 240 mg
Mepha Pharma AG
B
FB
G
IP
CI
Zilbrysq 16,6 mg
7
PR
PR
k.A.
solution pour injection en seringue pré-remplie: Zilucoplanum 16.6mg / 0.416ml
UCB-Pharma SA
A
FB
G
IP
Zilbrysq 32,4 mg
7
PR
PR
k.A.
solution pour injection en seringue pré-remplie: Zilucoplanum 32.4mg / 0.81ml
UCB-Pharma SA
A
FB
G
IP
Zilbrysq 23 mg
7
PR
PR
k.A.
solution pour injection en seringue pré-remplie: Zilucoplanum 23mg / 0.574ml
UCB-Pharma SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home